Citadel Advisors
BFRIW icon

Citadel Advisors’s Biofrontera BFRIW Stock Holding History

Citadel Advisors’s Portfolio BFRIW Stock Details BFRIW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-11,617
Closed -$465 – 14252
2024
Q2 		$465 Buy
11,617
+950
+9% +$49 ﹤0.01% 13986
2024
Q1 		$374 Buy
+10,667
New +$314 ﹤0.01% 14349

Other funds holding BFRIW

BA
Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return
CS
Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
US Bancorp
US Bancorp Minneapolis, Minnesota $82.4B AUM 19.69% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citadel Advisors's BFRIW Position: Q3 2024 in Review

Citadel Advisors sold out of Biofrontera (BFRIW) in Q3 2024, closing a stake of 11,617 shares — an estimated $465 sold.

Citadel Advisors first reported a position in BFRIW in Q1 2024 and held it in 2 quarters. The position peaked at $465 in Q2 2024. 6 funds tracked by Wall St. Rank hold BFRIW as of Q3 2024.

  • Citadel Advisors reported no remaining Biofrontera position as of Q3 2024 after selling out during the quarter.
  • Citadel Advisors sold 11,617 Biofrontera shares in Q3 2024, an estimated $465.
  • Citadel Advisors first reported a position in Biofrontera in Q1 2024 and held it in 2 quarters.
  • Citadel Advisors's Biofrontera position peaked at $465 in Q2 2024.
  • 6 funds tracked by Wall St. Rank held Biofrontera as of Q3 2024.

Based on Citadel Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.